Conrad N. Hilton Foundation’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-63,481
Closed -$7.85M 3
2020
Q4
$7.85M Buy
+63,481
New +$7.85M 100% 1